Strobeck Mark's Form 4/A amendment
AmendedRockwell Medical, Inc.RMTI · filed Jul 3, 2025
- Accession no.
- 0001628280-25-034186
- Filed
- Jul 3, 2025
- Trade date
- Jul 1, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Jul 2, 2025
This filing lists 1 non-derivative transaction. Open-market sales total $5.68K. It was filed 2 days after the trade.
This amendment replaces 0001628280-25-034068 (filed Jul 2, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Strobeck MarkCIK 0001599219 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Common Stock | SSaleDisposed | −6,926 | $0.82 | −$5,679.32 | 337,752 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024 in multiple trades at prices ranging from $0.81 to $0.84. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Remarks
This form is being amended to check the required box for sales pursuant to a Rule 10b5-1 Plan.